TD Cowen lowered the firm’s price target on Stem to $11 from $15 and keeps an Outperform rating on the shares. The analyst said we anticipate results to be broadly in line with consensus estimates and Stem’s implied 1Q23 guidance while investors will likely focus on the company s impending EBITDA profitability which is slated for 2H23.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on STEM:
- Stem initiated with a Market Perform at BMO Capital
- Stem downgraded to Peer Perform from Outperform at Wolfe Research
- Stem downgraded to Underperform at BofA on ‘waning confidence’
- Stem downgraded to Underperform from Neutral at BofA
- Buy These Clean Energy Stocks, Morgan Stanley Says, Forecasting Over 100% Upside